Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA2207135
Max Phase: Preclinical
Molecular Formula: C45H68N12O14S2
Molecular Weight: 1065.24
Molecule Type: Protein
Associated Items:
ID: ALA2207135
Max Phase: Preclinical
Molecular Formula: C45H68N12O14S2
Molecular Weight: 1065.24
Molecule Type: Protein
Associated Items:
Canonical SMILES: CC[C@H](C)[C@@H]1NC(=O)[C@H](Cc2ccc(O)cc2)NC(=O)[C@@H](N)CSSC[C@@H](C(=O)N2CCC[C@H]2C(=O)N[C@@H](CC(C)C)C(=O)NCC(=O)NCC(=O)O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC1=O
Standard InChI: InChI=1S/C45H68N12O14S2/c1-5-23(4)37-44(70)51-27(12-13-33(47)59)40(66)53-30(17-34(48)60)41(67)55-31(21-73-72-20-26(46)38(64)52-29(42(68)56-37)16-24-8-10-25(58)11-9-24)45(71)57-14-6-7-32(57)43(69)54-28(15-22(2)3)39(65)50-18-35(61)49-19-36(62)63/h8-11,22-23,26-32,37,58H,5-7,12-21,46H2,1-4H3,(H2,47,59)(H2,48,60)(H,49,61)(H,50,65)(H,51,70)(H,52,64)(H,53,66)(H,54,69)(H,55,67)(H,56,68)(H,62,63)/t23-,26-,27-,28-,29-,30-,31-,32-,37-/m0/s1
Standard InChI Key: WYDNURHNYIPCCU-GIISNQDKSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Protein | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1065.24 | Molecular Weight (Monoisotopic): 1064.4419 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Morris KM, Cao F, Onagi H, Altamore TM, Gamble AB, Easton CJ.. (2012) Prohormone-substrate peptide sequence recognition by peptidylglycine α-amidating monooxygenase and its reflection in increased glycolate inhibitor potency., 22 (23): [PMID:23084901] [10.1016/j.bmcl.2012.10.004] |
Source(1):